Praxis Precision Medicine Financials - Benzinga

Praxis Precision Medicines Inc

PRAXNASDAQ

Trade with Public

Trade with Public

$280.78

-1.01-0.36%

近くで: Sep 25, 5:00 PM EST

$280.78

N/A

時間外: 4:00 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Praxis Precision Medicine Financials

Praxis Precision Medicine (PRAX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Praxis Precision Medicine Q2 EPS $(2.87) Beats $(3.65) Estimate

Praxis Precision Medicine (NASDAQ:PRAX) reported quarterly losses of $(2.87) per share which beat the analyst consensus estimate of $(3.65) by 21.37 percent. This is a 13.29 percent increase over losses of $(3.31) per

Benzinga Newsdesk

PRO
Praxis Precision Medicine Q1 EPS $(3.20) Beats $(3.50) Estimate

Praxis Precision Medicine (NASDAQ:PRAX) reported quarterly losses of $(3.20) per share which beat the analyst consensus estimate of $(3.50) by 8.57 percent. This is a 2.74 percent increase over losses of $(3.29) per

Benzinga Newsdesk

Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results

Avi Kapoor

Earnings Breakdown: Praxis Precision Medicine Q4

Benzinga Insights

PRO
Praxis Precision Medicine Q4 EPS $(3.50) Misses $(3.08) Estimate

Praxis Precision Medicine (NASDAQ:PRAX) reported quarterly losses of $(3.50) per share which missed the analyst consensus estimate of $(3.08) by 13.67 percent. This is a 19.05 percent decrease over losses of $(2.94) per

Benzinga Newsdesk

Earnings Scheduled For February 19, 2026

Benzinga Insights

© 2026 Benzinga | All Rights Reserved